Contemporary evidence of long-term follow-up of the Epic<sup>TM</sup> prosthesis after mitral valve replacement
Our 10-year freedom from structural valve deterioration of 93.1% matches, and may even surpass those previously reported. The Epic porcine xenograft in mitral position has demonstrated to have excellent durability and long-term outcomes; representing an excellent option for patients in need for mitral valve replacement.
Authors
- Cándida Déniz (ORCID: https://orcid.org/0009-0000-6440-888X)
- Consuelo María Sisinni Ganly (ORCID: https://orcid.org/0000-0001-8410-0137)
- Beatriz Acuña Pais (ORCID: https://orcid.org/0000-0003-1323-9427)
- Rocío Casais Pampín (ORCID: https://orcid.org/0009-0008-7788-7259)
- Juan José Legarra (ORCID: https://orcid.org/0000-0003-4175-5787)
- Daniel Otero Lozano (ORCID: https://orcid.org/0000-0003-4353-1349)
Institutions
- University Hospital Complex Of Vigo (ES)
Publication Details
- Journal
- Journal of Cardiovascular and Thoracic Research
- Published
- 2025-09-28
- DOI
- https://doi.org/10.34172/jcvtr.025.33387
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00